Protecting People with Mental Disabilities and Impairments against Biomedical Research Abuse[*] By John H. Noble, Jr., Ph.D, The Catholic University of America, Washington, DC, USA Vera Hassner Sharav, MLS, Alliance for Human Research Protection, New York, USA People with mental disabilities and impairments historically have been targeted by biomedical researchers…
Concealed NIH Review Substantiates Fired Expert’s Concerns – AP Mon, 4 Jul 2005 The Associated Press reports that a 2004 internal report by the National Institutes of Health validates the allegations by Dr. Jonathan Fishbeing, the NIH ethics-safety expert who was fired for reporting unethical and scientifically flawed AIDS resesrch…
Netracor J & J heart Drug May Raise Risk of Dying Wed, 20 Apr 2005 A new research challenges the safety level linked with the drug ‘Natretor.’ Scios Inc., a subsidiary of Johnson & Johnson is the maker of “Natrecor.” “Researchers say that the use of heart-failure drug Natrecor results…
Fewer Kids Prescribed Drugs for Depression – WashPost Wed, 2 Feb 2005 A report by Medco revealing a decline in SSRI prescriptions for children is giving drug industry stakeholders nightmares about the cash flow. The Washington Post reports "medical groups such as the American Psychiatric Association and the American Academy…
AHRP Comments Re: EPA Proposed Rule for Human Pesticide Research Wed, 30 Nov 2005 Help us stop a proposed government policy that would lead to the proliferation of unthinkable human pesticide experiments such as the infamous CHEERS experiment. CHEERS was designed to expose toddlers to pesticides so that EPA investigators…
Is there hope for Psychiatry to make it as a profession? Tue, 14 Jun 2005 The New York Times reports: “Psychiatrists have been searching for more than a century for some biological marker for mental disease, to little avail.” Indeed, the latest embarassing controversy that perennially plagues the psychiatric establishment…
Lilly Shares Fall After BMJ Report About Prozac Documents – NYT Sat, 1 Jan 2005 The New York Times reports that Jeanne Lenzer’s investigative report in the current (Jan 1) British Medical Journal, citing Eli Lilly secret documents showing that company officials knew since 1988 that Prozac increased violent and…
Is Tamiflu worth it? Thu, 27 Oct 2005 Many knowledgable experts in pharmacology have expressed dismay over the hysteria mounting for Tamiflu, a drug that has shown to be only marginally effective at best in reducing ther number of days one experinces flu symptoms. In elderly patients who are at…
Corruption of Cong by Pharma: Greenwood offered job / drops Pharma hearing Tue, 20 Jul 2004 Related link: Cong Greenwood’s version Big Pharma buys a congressman and derails a public hearing focusing on pharmaceutical company concealment of evidence showing antidepressants increase risks of harm and show no benefit for children…
Data from Unpublished Trials Suggest that Most SSRI Antidepressant Drugs Unsuitable for Children Wed, 21 Apr 2004 An independent analysis in next week’s The Lancet compares the published and unpublished data of pediatric SSRI antidepressant clinical trial data, finding the published reports not to be evidence-based. “In a global medical…
Time for a Drug Test Registry_Marcia Angell_Why NIH is Not Up to the Task Fri, 13 Aug 2004 The uncovering of concealed, unpublished evidence showing that children suffered harm in antidepressant drug trials, has led to a rude public awakening. Selective reporting of clinical trial data has become “standard practice”…
NIH: Public Servant or Private Marketer? Wed, 22 Dec 2004 David Willman of the Los Angeles Times provides an important reminder that the FDA is not the only government healthcare agency to have betrayed the public trust and lost its credibility. While the FDA has lent its seal of approval…
